Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 186–186 | Cite as

Lutetium-(177lu)-oxodotreotide

Various toxicities: 4 case reports
Case report
  • 7 Downloads

Reference

  1. Zandee WT, et al. Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE. European Journal of Endocrinology 181: 45-53, No. 1, 1 May 2019. Available from: URL: http://doi.org/10.1530/EJE-18-0901 - Netherlands

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations